Key Takeaways
- • Courier Health raised $50 million in Series B funding led by Oak HC/FT, with participation from existing investors Norwest and Work-Bench, positioning the company to accelerate product innovation in patient experience management for life sciences.
- • The company addresses a critical operational failure in biopharma: approximately 30% of patients prescribed specialty medicines never initiate therapy, and 60-70% abandon treatment within the first year, representing a high-stakes market opportunity.
- • Courier Health quadrupled the number of therapies on its platform in 2025 and has delivered measurable customer outcomes including 15%+ increases in patient starts, 10-12% improvements in 6-month persistency rates, and 5-7x productivity gains for client teams.
- • The platform consolidates fragmented patient data from specialty pharmacy feeds, hub portals, claims systems, EHR signals, and field activity into unified patient records, addressing a structural pain point in biopharma's current toolkit of legacy CRMs and spreadsheet-based workflows.
- • Founded by Danny Sigurdson (former sales leader at ActionIQ), Courier Health has achieved traction with enterprise customers including Denali Therapeutics and SetPoint Medical, validating demand for next-generation patient navigation technology in the life sciences sector.
Summary
Courier Health announced a $50 million Series B funding round led by healthcare-focused venture firm Oak HC/FT, with continued support from existing investors Norwest and Work-Bench. The capital infusion will support product innovation and expansion of the company's patient experience orchestration platform across the life sciences industry.
The company operates in a market defined by significant operational inefficiency. Annually, nearly 7 billion prescriptions are dispensed in the United States, yet among patients prescribed specialty medicines—typically for chronic or rare diseases—approximately 30% never initiate therapy and 60-70% discontinue treatment within the first year. This represents not a clinical failure of the drugs themselves, but rather a breakdown in patient engagement and navigation infrastructure.
Courier Health's solution addresses this gap by consolidating the fragmented tools currently used across biopharma commercial organizations. Patient journeys are typically managed through disconnected systems including legacy CRM platforms designed for sales representatives, specialty pharmacy feeds, hub portals, claims databases, electronic health records, and email coordination. Courier Health ingests these disparate data streams, stitches them into unified patient records, surfaces intelligence on at-risk patients, and orchestrates compliant actions across internal teams.
The company demonstrated significant operational traction in 2025, quadrupling the number of therapies on its platform. Customers have reported substantial improvements: over 15% increases in patient starts, 10-12% improvements in 6-month persistency rates, and 5-7x productivity gains for commercial teams. Notable customers including Denali Therapeutics and SetPoint Medical have characterized the platform as a next-generation advancement in life sciences patient navigation. Founder Danny Sigurdson drew on prior experience at ActionIQ, where he identified similar data fragmentation challenges affecting enterprise customer data management, recognizing the stakes are materially higher in biopharma where operational failures directly impact patient access to therapeutic interventions.
The company operates in a market defined by significant operational inefficiency. Annually, nearly 7 billion prescriptions are dispensed in the United States, yet among patients prescribed specialty medicines—typically for chronic or rare diseases—approximately 30% never initiate therapy and 60-70% discontinue treatment within the first year. This represents not a clinical failure of the drugs themselves, but rather a breakdown in patient engagement and navigation infrastructure.
Courier Health's solution addresses this gap by consolidating the fragmented tools currently used across biopharma commercial organizations. Patient journeys are typically managed through disconnected systems including legacy CRM platforms designed for sales representatives, specialty pharmacy feeds, hub portals, claims databases, electronic health records, and email coordination. Courier Health ingests these disparate data streams, stitches them into unified patient records, surfaces intelligence on at-risk patients, and orchestrates compliant actions across internal teams.
The company demonstrated significant operational traction in 2025, quadrupling the number of therapies on its platform. Customers have reported substantial improvements: over 15% increases in patient starts, 10-12% improvements in 6-month persistency rates, and 5-7x productivity gains for commercial teams. Notable customers including Denali Therapeutics and SetPoint Medical have characterized the platform as a next-generation advancement in life sciences patient navigation. Founder Danny Sigurdson drew on prior experience at ActionIQ, where he identified similar data fragmentation challenges affecting enterprise customer data management, recognizing the stakes are materially higher in biopharma where operational failures directly impact patient access to therapeutic interventions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.